Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer

Author： Junttila Teemu   Li Guangmin   Parsons Kathryn   Phillips Gail   Sliwkowski Mark  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.128, Iss.2, 2011-07, pp. : 347-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model

By        

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1087-1093

Spandidos Publications

Access to resources Recommend Favorite

T-DM1 in breast cancer therapeutics: the first drug of its generation

By Karamouzis Michalis V  

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 267-270

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer brain metastases responding to primary systemic therapy with T-DM1

By Bartsch Rupert   Berghoff Anna   Preusser Matthias  

Journal of Neuro-Oncology, Vol. 116, Iss. 1, 2014-01 ,pp. : 205-206

Springer Publishing Company

Access to resources Recommend Favorite

Mechanisms of Trastuzumab Resistance in Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 3, 2009-03 ,pp. : 348-355

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 151-162

Bentham Science Publishers

Access to resources Recommend Favorite